RxDoctor Payments Data

Richard Campbell, APRN

Adult Health · Voorhees, NJNPI 1114681970

Payments from drug & device makers

$1,301in general payments, 2019–2025

Across 94 payments — averaging $13.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$476
  • AstraZeneca$135
  • Regeneron Healthcare Solutions, Inc.$104
  • AbbVie$100
  • Philips North America LLC$90
  • Sanofi$89
  • plus $306 from 10 others

What the payments were for

  • Food & beverage$1,301100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,301 in reported general payments places this provider in the 75th percentile of 1,135 adult health providers in New Jersey.

See all adult health providers in New Jersey

Medicare billing

Part B allowed, 2024
$36,275
Medicare patients
316
Services billed
366

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter84$77,183
NucalaMepolizumab17$66,452
EliquisApixaban25$19,892
Breo ElliptaFluticasone/Vilanterol28$16,212
Breztri AerosphereBudesonide/Glycopyr/Formoterol24$14,732
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr30$13,987
Albuterol Sulfate HfaAlbuterol Sulfate79$2,956
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$2,242
Azelastine-FluticasoneAzelastine/Fluticasone13$1,655
Montelukast Sodium78$1,350
Fluticasone Propionate44$742
Ipratropium Bromide14$359
Pantoprazole Sodium18$268
CefuroximeCefuroxime Axetil14$161
Prednisone59$138

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Nucala, Breo Ellipta, Anoro Ellipta$476$173,834159 claims
AstraZenecaBreztri Aerosphere$135$14,73224 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,135 adult health providers in New Jersey.

Other adult health in Voorhees

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →